Cargando…

A novel mechanism of ferroptosis surveillance offers promising therapeutic avenues for breast and prostate cancers

Detalles Bibliográficos
Autores principales:	Xu, Rongyang, Wang, Luyao, Qu, Shanqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2023
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513963/ https://www.ncbi.nlm.nih.gov/pubmed/37735316 http://dx.doi.org/10.1186/s43556-023-00140-4

Ejemplares similares

Targeting the ferroptosis crosstalk: novel alternative strategies for the treatment of major depressive disorder
por: Wang, Luyao, et al.
Publicado: (2023)

In search for novel strategies towards neuroprotection and neuroregeneration: is PPARα a promising therapeutic target?
por: Moreno, Sandra, et al.
Publicado: (2015)

Targeting ferroptosis opens new avenues for the development of novel therapeutics
por: Sun, Shumin, et al.
Publicado: (2023)

Ketogenic diet: new avenues to overcome colorectal cancer
por: Xiang, Yuancai, et al.
Publicado: (2022)

Promising avenues of therapeutics for bipolar illness
por: Post, Robert M.
Publicado: (2008)

Modulating serine palmitoyltransferase‐deoxysphingolipid axis in cancer therapy
por: Xiang, Yuancai, et al.
Publicado: (2020)

Offering healthier food options
por: Barnes, Katharine
Publicado: (2021)

Tumor neutrophils ferroptosis: a targetable immunosuppressive mechanism for cancer immunotherapy
por: Du, Songtao, et al.
Publicado: (2023)

IL4I1-driven AHR signature: a new avenue for cancer therapy
por: Wang, Zuli, et al.
Publicado: (2021)

Epigenetic mechanisms in migraine: a promising avenue?
por: Eising, Else, et al.
Publicado: (2013)

New Promising Therapeutic Avenues of Curcumin in Brain Diseases
por: Benameur, Tarek, et al.
Publicado: (2021)

Ferroptosis: the Good, the Bad and the Ugly
por: Aldrovandi, Maceler, et al.
Publicado: (2020)

Peroxisome: the new player in ferroptosis
por: Tang, Daolin, et al.
Publicado: (2020)

Relugolix as a promising novel oral GnRH antagonist for prostate cancer treatment
por: Lv, Jialu, et al.
Publicado: (2020)

Targeting menin: a promising therapeutic strategy for susceptible acute leukemia subtypes
por: Di Fazio, Pietro
Publicado: (2023)

Exosomes: A Promising Avenue for the Diagnosis of Breast Cancer
por: Meng, Yiming, et al.
Publicado: (2019)

Does DPP-IV Inhibition Offer New Avenues for Therapeutic Intervention in Malignant Disease?
por: Busek, Petr, et al.
Publicado: (2022)

Diabetic Nephropathy: Novel Molecular Mechanisms and Therapeutic Avenues
por: Oltean, Sebastian, et al.
Publicado: (2017)

Targeting the entry step of SARS-CoV-2: a promising therapeutic approach
por: Li, Jing, et al.
Publicado: (2020)

Constrained surfaces: promising therapeutic targets for COVID-19 determined by systematically mutational analysis
por: Wang, Manni, et al.
Publicado: (2021)

Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches
por: Merino‐Vico, Ana, et al.
Publicado: (2022)

Volatilomics: An Emerging and Promising Avenue for the Detection of Potential Prostate Cancer Biomarkers
por: Berenguer, Cristina V., et al.
Publicado: (2022)

Unmasking metabolic dependencies in pancreatic cancer: aberrant polyamine synthesis as a promising new therapeutic target
por: Wolters-Eisfeld, Gerrit, et al.
Publicado: (2023)

Breast Cancer CAFs: Spectrum of Phenotypes and Promising Targeting Avenues
por: Elwakeel, Eiman, et al.
Publicado: (2021)

Hydrogen sulfide controls peripheral nerve degeneration and regeneration: a novel therapeutic strategy for peripheral demyelinating disorders or nerve degenerative diseases
por: Jung, Junyang, et al.
Publicado: (2014)

48. TOPICAL CAPTOPRIL: A PROMISING THERAPEUTIC AVENUE FOR LYMPHEDEMA TREATMENT
por: Brown, Stav, et al.
Publicado: (2022)

Targeting calcium signaling in Alzheimer’s disease: challenges and promising therapeutic avenues
por: Song, LinLin, et al.
Publicado: (2023)

Dysregulated neutrophilic cell death in SLE: a spotlight on ferroptosis
por: Ohl, Kim, et al.
Publicado: (2021)

The promising role of poly(ADP-ribose) polymerase inhibitors in prostate cancer
por: Aragon-Ching, Jeanny B
Publicado: (2016)

Emerging significance and therapeutic targets of ferroptosis: a potential avenue for human kidney diseases
por: Li, Jinghan, et al.
Publicado: (2023)

ACSL4, PUFA, and ferroptosis: new arsenal in anti-tumor immunity
por: Gan, Boyi
Publicado: (2022)

CRISPR/Cas9 offers a new tool for studying the role of chromatin architecture in disease pathogenesis
por: Guo, Xiang, et al.
Publicado: (2018)

Interferon-beta offers promising avenues to COVID-19 treatment: a systematic review and meta-analysis of clinical trial studies
por: Nakhlband, Ailar, et al.
Publicado: (2021)

Extension of the therapeutic spectrum in castration-resistant prostate cancer: Osteoclast inhibition with denosumab
por: Wolff, Johannes M., et al.
Publicado: (2012)

Editorial: Immune Surveillance of the HIV Reservoir: Mechanisms, Therapeutic Targeting and New Avenues for HIV Cure
por: Prado, Julia G., et al.
Publicado: (2020)

Promising biotechnological applications of antibiofilm exopolysaccharides
por: Bernal, Patricia, et al.
Publicado: (2012)

Tools to identify the men with prostate cancer most appropriate for active surveillance?
por: Getzenberg, Robert H
Publicado: (2014)

Innate immune signaling and immunothrombosis: New insights and therapeutic opportunities
por: Ryan, Tristram A. J., et al.
Publicado: (2022)

Regulatory T cells as a therapeutic approach for inflammatory bowel disease
por: Laukova, Marcela, et al.
Publicado: (2023)

Surveilling microglia dampens neuronal activity: operation of a purinergically mediated negative feedback mechanism
por: Illes, Peter, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sjdlqis9k58dpnolie8u9mp27e